Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Eicosapentaenoic Acid supplementation changes Fatty Acid composition and corrects endothelial dysfunction in hyperlipidemic patients.

Yamakawa K, Shimabukuro M, Higa N, Asahi T, Ohba K, Arasaki O, Higa M, Oshiro Y, Yoshida H, Higa T, Saito T, Ueda S, Masuzaki H, Sata M.

Cardiol Res Pract. 2012;2012:754181. doi: 10.1155/2012/754181. Epub 2012 Dec 26.

2.
3.
4.
5.

Dietary alpha-linolenic acid, EPA, and DHA have differential effects on LDL fatty acid composition but similar effects on serum lipid profiles in normolipidemic humans.

Egert S, Kannenberg F, Somoza V, Erbersdobler HF, Wahrburg U.

J Nutr. 2009 May;139(5):861-8. doi: 10.3945/jn.108.103861. Epub 2009 Mar 4.

7.

Effect of omega-3 fatty acid supplementation on the arachidonic acid:eicosapentaenoic acid ratio.

Burns T, Maciejewski SR, Hamilton WR, Zheng M, Mooss AN, Hilleman DE.

Pharmacotherapy. 2007 May;27(5):633-8.

PMID:
17461697
8.
9.

The effects of omega-3 polyunsaturated (correction of polyunsatulated) fatty acids on the recovery of cardiac function following cold preservation and reperfusion in hyperlipidemic rats.

Ku K, Nosaka S, Hashimoto M, Kin S, Saitoh Y, Alam MS, Masumura S, Nakayama K.

Transplantation. 1996 Sep 27;62(6):735-42.

PMID:
8824469
10.

Effects of alpha-linolenic acid versus those of EPA/DHA on cardiovascular risk markers in healthy elderly subjects.

Goyens PL, Mensink RP.

Eur J Clin Nutr. 2006 Aug;60(8):978-84. Epub 2006 Feb 15.

PMID:
16482073
12.

Effects of four doses of n-3 fatty acids given to hyperlipidemic patients for six months.

Harris WS, Windsor SL, Dujovne CA.

J Am Coll Nutr. 1991 Jun;10(3):220-7.

PMID:
1832701
14.

Addition of eicosapentaenoic acid to gamma-linolenic acid-supplemented diets prevents serum arachidonic acid accumulation in humans.

Barham JB, Edens MB, Fonteh AN, Johnson MM, Easter L, Chilton FH.

J Nutr. 2000 Aug;130(8):1925-31.

15.
17.

The effects of pitavastatin, eicosapentaenoic acid and combined therapy on platelet-derived microparticles and adiponectin in hyperlipidemic, diabetic patients.

Nomura S, Inami N, Shouzu A, Omoto S, Kimura Y, Takahashi N, Tanaka A, Urase F, Maeda Y, Ohtani H, Iwasaka T.

Platelets. 2009 Feb;20(1):16-22. doi: 10.1080/09537100802409921.

PMID:
19172517
20.

Encapsulated fish oil enriched in alpha-tocopherol alters plasma phospholipid and mononuclear cell fatty acid compositions but not mononuclear cell functions.

Yaqoob P, Pala HS, Cortina-Borja M, Newsholme EA, Calder PC.

Eur J Clin Invest. 2000 Mar;30(3):260-74.

PMID:
10692004

Supplemental Content

Support Center